MARKET

IRWD

IRWD

Ironwood
NASDAQ
3.060
-0.090
-2.86%
After Hours: 3.040 -0.02 -0.65% 19:13 03/27 EDT
OPEN
3.100
PREV CLOSE
3.150
HIGH
3.200
LOW
3.030
VOLUME
1.35M
TURNOVER
--
52 WEEK HIGH
5.78
52 WEEK LOW
0.5271
MARKET CAP
498.96M
P/E (TTM)
20.76
1D
5D
1M
3M
1Y
5Y
1D
Top 10 undervalued small-cap stocks with high growth grades
Seeking Alpha · 1d ago
Weekly Report: what happened at IRWD last week (0316-0320)?
Weekly Report · 5d ago
Craig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD)
TipRanks · 03/19 07:35
Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility
Seeking Alpha · 03/18 17:25
Ironwood Pharmaceuticals director Alexander J. Denner disposes of shares worth USD 20.53 million
Reuters · 03/18 00:35
Weekly Report: what happened at IRWD last week (0309-0313)?
Weekly Report · 03/16 09:59
Small-Cap healthcare stocks ranked by quant ratings after earnings season
Seeking Alpha · 03/13 13:55
Analysts Offer Insights on Healthcare Companies: Ironwood Pharma (IRWD) and Opus Genetics (IRD)
TipRanks · 03/11 13:50
More
About IRWD
Ironwood Pharmaceuticals, Inc. is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI), and rare diseases. It is focused on the development and commercialization of GI product opportunities in areas of significant unmet need. LINZESS (linaclotide), its commercial product, is indicated for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C), or chronic idiopathic constipation (CIC), and for pediatric patients ages 6-17 years-old suffering from functional constipation (FC). Linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC and pediatric patients. The Company is also engaged in advancing apraglutide, a synthetic long-acting peptide analog of glucagon-like peptide-2 (GLP-2), for short bowel syndrome (SBS), patients who are dependent on parenteral support.

Webull offers Ironwood Pharmaceuticals, Inc. stock information, including NASDAQ: IRWD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IRWD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IRWD stock methods without spending real money on the virtual paper trading platform.